Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home AI & Quantum Computing

Rigetti Computing: Can Technological Promise Offset Mounting Financial Losses?

Dieter Jaworski by Dieter Jaworski
November 12, 2025
in AI & Quantum Computing, Analysis, Earnings, Nasdaq, Tech & Software
0
Rigetti Stock
0
SHARES
149
VIEWS
Share on FacebookShare on Twitter

Quantum computing represents one of the most promising technological frontiers, yet companies like Rigetti Computing face a critical challenge: balancing ambitious technological roadmaps against persistent financial underperformance. Following the release of its latest quarterly figures, the company’s stock declined by more than 5%, reflecting investor apprehension despite notable technical achievements.

A Deeper Look at the Financials

For the third quarter of 2025, Rigetti Computing reported revenue of $1.9 million. This figure marks an 18% decrease compared to the prior year and fell short of analyst expectations, which had been set at $2.2 million. This revenue contraction presents a puzzling contrast to the company’s recent commercial announcements. Rigetti secured orders valued at approximately $5.7 million for two of its 9-qubit quantum computers and entered into a three-year, $5.8 million contract with the Air Force Research Laboratory.

This divergence highlights a common characteristic of capital-intensive, growth-phase technology firms: a significant lag often exists between booking an order and recognizing the corresponding revenue.

Dissecting a $201 Million Loss

A headline-grabbing GAAP loss of $201 million for the quarter demands closer scrutiny. The underlying operational reality is less dire. The company’s adjusted loss came in at just $10.7 million, a figure that actually surpassed analyst forecasts. The massive discrepancy is primarily attributed to non-cash accounting losses stemming from the revaluation of stock options in a highly volatile market.

The actual operating loss was reported at $20.5 million. While such a burn rate is not unusual for a company in its development stage, sustaining these levels long-term is untenable without a substantial and accelerating revenue stream.

Should investors sell immediately? Or is it worth buying Rigetti?

A Substantial Cash Cushion Provides Runway

On a more positive note, Rigetti’s balance sheet shows significant strength. The company currently holds approximately $600 million in liquid assets, a notable increase from its position at the end of September. A substantial inflow of $46.5 million came from the exercise of stock warrants. This robust financial safety net affords Rigetti the necessary time to pursue its aggressive technological milestones:

  • Development of a 100+ qubit system with 99.5% gate fidelity by the end of 2025
  • A 150+ qubit system targeted for the end of 2026
  • A 1,000+ qubit system planned for the end of 2027

The central question for investors remains whether this timeline is sufficient to achieve market-ready, profitable technology.

Strategic Alliances and Market Volatility

To solidify its standing within the quantum ecosystem, Rigetti is increasingly focusing on strategic collaborations. Its partnership with NVIDIA on the NVQLink platform, along with cooperative efforts with Indian and American research institutions, signals a strategic pivot toward becoming an infrastructure provider for hybrid quantum-classical AI applications.

The success of this strategy is entirely dependent on when—or if—commercially viable quantum applications become a widespread reality. The market’s skepticism is palpable, reflected in the stock’s extreme volatility. Shares have swung from a low of $1.25 to a high of over $58 within a single twelve-month period, underscoring deep investor uncertainty regarding the timeline for meaningful commercial breakthroughs in quantum computing.

Ad

Rigetti Stock: Buy or Sell?! New Rigetti Analysis from February 7 delivers the answer:

The latest Rigetti figures speak for themselves: Urgent action needed for Rigetti investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Rigetti: Buy or sell? Read more here...

Tags: Rigetti
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Viking Therapeutics Stock
Earnings

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

February 7, 2026
Diginex Stock
Blockchain

Diginex Enters Critical Implementation Phase Following Strategic Moves

February 7, 2026
Deluxe Stock
Analysis

Deluxe Stock Gains Momentum on Successful Fintech Transition

February 6, 2026
Next Post
Helmerich, Payne Stock

Helmerich & Payne Shares Approach Critical Juncture

QuantumScape Stock

Insider Selling Raises Questions About QuantumScape's Future

JinkoSolar Stock

JinkoSolar Shares Approach Critical Juncture

Recommended

Jakks Pacific Reports Disappointing Q4 2023 Earnings

2 years ago
Ecommerce Stock Exchange

Notable Options Market Activity for Shopify

2 years ago
Fannie Mae Stock

Fannie Mae’s Public Offering Plans Derailed by Prominent Investor

3 months ago
Ocugen Stock

Ocugen Shares Face Critical Test Amid Steep Decline

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

Vir Biotechnology’s 2026 Pipeline: A Year of Pivotal Clinical Data

Tellurian Acquisition Finalized as Woodside Takes Control

Coherus BioSciences Forges Key Oncology Alliance with Janssen

TCG BDC Investors Await Key Financial Milestones

Trending

Viking Therapeutics Stock
Earnings

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

by Rodolfo Hanigan
February 7, 2026
0

Investors in Viking Therapeutics are currently focused on a specific calendar event rather than breaking news. The...

Diginex Stock

Diginex Enters Critical Implementation Phase Following Strategic Moves

February 7, 2026
Deluxe Stock

Deluxe Stock Gains Momentum on Successful Fintech Transition

February 6, 2026
Hydrofarm Holdings Inc Stock

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

February 6, 2026
Northeast Bancorp Stock

Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

February 6, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment
  • Diginex Enters Critical Implementation Phase Following Strategic Moves
  • Deluxe Stock Gains Momentum on Successful Fintech Transition

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com